3494 related articles for article (PubMed ID: 16174987)
1. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
3. IgE profiles of Bermuda grass pollen sensitised patients evaluated by Phleum pratense allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12.
Rossi RE; Monasterolo G; Prina P; Coco G; Operti D; Rossi L
Allergol Int; 2008 Jun; 57(2):157-64. PubMed ID: 18349590
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
[TBL] [Abstract][Full Text] [Related]
5. Identification of cross-reactive and genuine Parietaria judaica pollen allergens.
Stumvoll S; Westritschnig K; Lidholm J; Spitzauer S; Colombo P; Duro G; Kraft D; Geraci D; Valenta R
J Allergy Clin Immunol; 2003 May; 111(5):974-9. PubMed ID: 12743560
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy.
Tripodi S; Frediani T; Lucarelli S; Macrì F; Pingitore G; Di Rienzo Businco A; Dondi A; Pansa P; Ragusa G; Asero R; Faggian D; Plebani M; Matricardi PM
J Allergy Clin Immunol; 2012 Mar; 129(3):834-839.e8. PubMed ID: 22206774
[TBL] [Abstract][Full Text] [Related]
7. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens.
Lombardero M; García-Sellés FJ; Polo F; Jimeno L; Chamorro MJ; García-Casado G; Sánchez-Monge R; Díaz-Perales A; Salcedo G; Barber D
Clin Exp Allergy; 2004 Sep; 34(9):1415-21. PubMed ID: 15347375
[TBL] [Abstract][Full Text] [Related]
9. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
11. Component-resolved diagnosis for phleum allergy: the role of recombinants.
De Amici M; Alesina R; Moratti R; Ciprandi G
J Asthma; 2010 Sep; 47(7):750-3. PubMed ID: 20726834
[TBL] [Abstract][Full Text] [Related]
12. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
Klimek L; Schendzielorz P; Pinol R; Pfaar O
Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
[TBL] [Abstract][Full Text] [Related]
13. Parietaria profilin shows only limited cross-reactivity with birch and grass profilins.
Asero R; Mistrello G; Roncarolo D; Amato S
Int Arch Allergy Immunol; 2004 Feb; 133(2):121-4. PubMed ID: 14739580
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.
Sharma S; Panzani RC; Gaur SN; Ariano R; Singh AB
Int Arch Allergy Immunol; 2005 Feb; 136(2):103-12. PubMed ID: 15650307
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, and Phl p 5) in a random sample of patients with specific IgE to Phleum pratense.
Rossi RE; Monasterolo G; Operti D; Operti R; Berlen R
Allergy; 2000 Feb; 55(2):181-4. PubMed ID: 10726734
[TBL] [Abstract][Full Text] [Related]
16. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
Paranos S; Petrović S; Vojović I
Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
[TBL] [Abstract][Full Text] [Related]
17. Rush sublingual immunotherapy in Parietaria allergic patients.
D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin E reactivity to cross-reacting panallergen components in north-eastern Poland patients pollen sensitized.
Kowal K; Pampuch A; Sacharzewska E; Swiebocka E; Siergiejko Z; Siergiejko G; Chruszcz M; DuBuske L
Allergy Asthma Proc; 2020 May; 41(3):183-191. PubMed ID: 32375962
[No Abstract] [Full Text] [Related]
19. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
20. Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy.
Letrán A; Espinazo M; Moreno F
Ann Allergy Asthma Immunol; 2013 Oct; 111(4):295-7. PubMed ID: 24054367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
